ENANTIOS - AixPoint Portfolio
ENANTIOS builds Raman Optical Activity instruments for chiral analysis. CHF 1.8M seed, CE Mark, top-10 pharma customers. AixPoint advises on IP and go-to-market.
ENANTIOS
Chirality, measured. Raman Optical Activity instruments for pharma.
ENANTIOS is a Swiss precision-optics company building Raman Optical Activity (ROA) instruments that resolve a long-standing bottleneck in chiral analysis for pharmaceutical and biotech development.
After a CHF 1.8M seed in 2024 (Privilège Ventures, Zürcher Kantonalbank), the company shipped its first commercial instrument to Bar-Ilan University in 2025, achieved CE certification under MDR, and now counts two of the top-10 global pharma firms as customers.
ENANTIOS is the textbook deep-tech bet: hard science, narrow market, defensible IP. AixPoint advises on patent portfolio architecture and the transition from measurement-as-a-service to product company.
Precision Optics · Seed · CH · 2020